Robert C. Owens

9.7k citations

59 papers · 7.3k indexed · 3 hit papers · h-index 29

Impact in

Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
Critical Care and Intensive Care Medicine top 0.2%
- Nosocomial Infections in ICU

Papers in

Applied Microbiology and Biotechnology 15
- Antibiotic Use and Resistance 15
Molecular Medicine 18
- Antibiotic Resistance in Bacteria 18

Co-authors: Dale N. Gerding Paul G. Ambrose Carlene A. Muto Thomas M. Hooton Timothy H. Dellit George Killgore Sophia V. Kazakova Stuart Johnson
Journals: Clinical Infectious Diseases (10 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (5 papers)Diagnostic Microbiology and Infectious Disease (5 papers)International Journal of Antimicrobial Agents (4 papers)American Journal of Health-System Pharmacy (4 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Robert C. Owens

59 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

Antimicrobial‐Associated Risk Factors forClostridium difficileInfection 2008 · 487 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Clinical Infectious Diseases
2006 Clinical Infectious Diseases
2005 New England Journal of Medicine

Peers

Countries citing papers authored by Robert C. Owens

Since Specialization

Citations

This map shows the geographic impact of Robert C. Owens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Owens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Owens more than expected).

Fields of papers citing papers by Robert C. Owens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert C. Owens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Owens. The network helps show where Robert C. Owens may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert C. Owens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert C. Owens Line = papers co-authored together Robert C. Owens links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacokinetics–pharmacodynamics, computer decision support technologies, and antimicrobial stewardship: the compass and rudder Diagnostic Microbiology and Infectious Disease ·Robert C. Owens, Catharine C. Bulik, David R. Andes	2018	7
2	Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects Clinical Drug Investigation ·冯苏, Robert C. Owens, Sailaja Puttagunta, Mark Yen, Michael W. Dunne	2015	15
3	Need and Potential of Antimicrobial Stewardship in Community Hospitals Clinical Infectious Diseases ·Edward Septimus, Robert C. Owens	2011	98
4	Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Richard H. Drew, Roger L. White, Conan MacDougall, Elizabeth D. Hermsen, Robert C. Owens	2009	62
5	Antimicrobial Stewardship: Application in the Intensive Care Unit Infectious Disease Clinics of North America ·Robert C. Owens	2009	11
6	Community Transmission in the United States (US) of a Confirmed CTX M-15-Producing Sequence Type ST131 Escherichia coli Strain Resulting in Death 46th Annual Meeting ·Robert C. Owens	2008	1
7	Measures to Control and PreventClostridium difficileInfection Clinical Infectious Diseases ·Dale N. Gerding, Carlene A. Muto, Robert C. Owens	2008	243
8	Results of Survey on Implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship Infection Control and Hospital Epidemiology ·Scott D. Pope, Timothy H. Dellit, Robert C. Owens, Thomas M. Hooton	2008	73
9	Clostridium difficile infection: A critical overview Current Infectious Disease Reports ·Qi Lu, 武明雨, Robert C. Owens	2008	11
10	Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin The American Journal of Medicine ·Robert C. Owens, Kenneth C. Lamp, Lawrence V. Friedrich, M Lüscher-Mattii	2007	30
11	Hospital-Based Strategies for Combating Resistance Clinical Infectious Diseases ·Robert C. Owens, Louis B. Rice	2006	54
12	Antimicrobial Safety: Focus on Fluoroquinolones Clinical Infectious Diseases ·Robert C. Owens, Paul G. Ambrose	2005	313
13	Antimicrobial Stewardship Programs as a Means to Optimize Antimicrobial Use Insights from the Society of Infectious Diseases Pharmacists Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Robert C. Owens, Gilles L. Fraser, Patricia Stogsdill	2004	73
14	QT Prolongation with Antimicrobial Agents Drugs ·Robert C. Owens	2004	94
15	Optimizing antimicrobial dosing in the critically ill patient Current Opinion in Critical Care ·John E. Goldberg, Robert C. Owens	2002	22
16	ANTIMICROBIAL PHARMACODYNAMICS Medical Clinics of North America ·Paul G. Ambrose, Robert C. Owens, Dennis M. Grasela	2000	15
17	Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia International Journal of Antimicrobial Agents ·Cyprian O. Onyeji, Qin Kunpeng, Robert C. Owens, David P. Nicolau, Richard Quintiliani, Charles H. Nightingale	1999	34
18	ANTIBIOTIC USE IN THE CRITICAL CARE UNIT Critical Care Clinics ·Paul G. Ambrose, Robert C. Owens, Richard Quintiliani, Neil S. Yeston, Helen M. Crowe, Burke A. Cunha, Charles H. Nightingale	1998	8
19	Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and cefuroxime axetil against Streptococcus pneumoniae International Journal of Antimicrobial Agents ·Melinda K. Lacy, Robert C. Owens, Bruno Valentim, David P. Nicolau, Richard Quintiliani, Charles H. Nightingale	1998	8
20	Ceftibuten: An Overview Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Robert C. Owens, Charles H. Nightingale, David P. Nicolau	1997	8

About Robert C. Owens

Robert C. Owens is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Pharmacology, Clinical Biochemistry and Critical Care and Intensive Care Medicine, having authored 59 papers that have together received 7.3k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Antibiotic Resistance in Bacteria (18 papers), Pneumonia and Respiratory Infections (15 papers), Antibiotic Use and Resistance (15 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Identification and Susceptibility Testing (10 papers), Clostridium difficile and Clostridium perfringens research (9 papers) and Microscopic Colitis (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (2.6k citations), Critical Care and Intensive Care Medicine (1.1k citations), Infectious Diseases (3.4k citations), Molecular Medicine (912 citations) and Clinical Biochemistry (1.1k citations). Robert C. Owens has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Dale N. Gerding, Paul G. Ambrose, Carlene A. Muto, Thomas M. Hooton, Timothy H. Dellit, George Killgore, Sophia V. Kazakova, Stuart Johnson, Angela Thompson and L. Clifford McDonald. Their work appears in journals such as Clinical Infectious Diseases, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Diagnostic Microbiology and Infectious Disease, International Journal of Antimicrobial Agents and American Journal of Health-System Pharmacy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact